Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
JDE Peet`s N.V. | JDEP | Mar 3, 2021 | 33.31 | +0.27 |
Just Eat Takeaway.com N.V. | TKWY | Mar 3, 2021 | 78.30 | -2.15 |
Kempen European High Divividend Fund NV - N. | KEHDF | Mar 3, 2021 | 6.40 | +0.16 |
Kempen European Property Fund NV. | KBEPF | Mar 3, 2021 | 16.61 | -0.42 |
Kempen GlobalHigh Div.Fund NV - N | KGHDF | Mar 3, 2021 | 31.10 | +0.29 |
Kempen Orange Fund N.V. | KORAF | Mar 3, 2021 | 119.42 | -0.87 |
Kempen Oranje Participaties N.V. | KORPT | Mar 3, 2021 | 245.36 | 0.00 |
Kempen Profielfonds 2 | LANDE | Mar 3, 2021 | 38.48 | +0.76 |
Kempen Profielfonds 3 | LANNE | Mar 3, 2021 | 40.41 | +1.38 |
Kempen Profielfonds 4 | LANGR | Mar 3, 2021 | 40.77 | 0.00 |
Kempen Profielfonds 5 | LANOF | Mar 3, 2021 | 42.37 | +1.85 |
Kendrion NV | KENDR | Mar 3, 2021 | 22.45 | +4.42 |
Kiadis Pharma NV | KDS | Mar 3, 2021 | 5.40 | 0.00 |
Koninklijke Ahold Delhaize N.V. | AD | Mar 3, 2021 | 21.72 | -0.23 |
Koninklijke BAM Groep NV | BAMNB | Mar 3, 2021 | 2.34 | +2.46 |
Koninklijke Boskalis Westminster NV | BOKA | Mar 3, 2021 | 25.68 | +0.47 |
Koninklijke Brill NV | BRILL | Mar 3, 2021 | 22.20 | -2.63 |
Koninklijke DSM NV | DSM | Mar 3, 2021 | 138.75 | -0.68 |
Koninklijke KPN NV | KPN | Mar 3, 2021 | 2.82 | -1.78 |
Koninklijke Porceleyne Fles | PORF | Mar 3, 2021 | 9.20 | 0.00 |
Koninklijke Vopak NV | VPK | Mar 3, 2021 | 40.06 | +0.96 |
Lavide Holding NV | LVIDE | Mar 3, 2021 | 1.26 | -4.55 |
Legends Funds | THXLE | Mar 3, 2021 | 136.75 | -1.09 |
LSP Life Sciences Fund | LSP | Mar 3, 2021 | 295.37 | -1.40 |
Lucas Bols N.V. | BOLS | Mar 3, 2021 | 10.60 | +0.47 |
Marel | MAREL | Mar 3, 2021 | 5.80 | 0.00 |
Microsoft Corporation | MSF | Mar 3, 2021 | 231.00 | -1.37 |
Midkap-index | AMX | Mar 3, 2021 | 989.33 | -0.01 |
MKB Nedsense | NEDSE | Mar 3, 2021 | 0.18 | +1.69 |
Morefield Group | MORE | Mar 3, 2021 | 0.53 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.